SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-18-011187
Filing Date
2018-01-16
Accepted
2018-01-16 16:06:58
Documents
4
Group Members
RODERICK WONG

Document Format Files

Seq Description Document Type Size
1 SC 13D d514948dsc13d.htm SC 13D 51855
2 EX-99.2 d514948dex992.htm EX-99.2 3456
3 EX-99.3 d514948dex993.htm EX-99.3 7842
4 EX-99.4 d514948dex994.htm EX-99.4 8184
  Complete submission text file 0001193125-18-011187.txt   73107
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Subject) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88750 | Film No.: 18528674
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D